The Latest Breaking News from WAT

Waters has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects.

Waters Corporation has underperformed relative to the S&P 500 Index over the past year, and Wall Street analysts remain cautious about the stock’s prospects.

Waters is set to release its second-quarter earnings later this month, and analysts project a single-digit earnings dip.

The diagnostics and research industry has witnessed significant growth over the past couple years due to the pandemic-driven tailwinds, growing prevalence of chronic diseases, and rising adoption of advanced technologies. Thus, shares of fundamentally-sound companies Agilent Technologies (A), Waters Corp. (WAT), and Laboratory Corporation of America Holdings (LH) could be…

Waters Corp (NYSE:WAT) reported first-quarter FY22 revenue growth of 16% year-on-year in CC to $690.6 million, above the consensus of $632.8 million. Sales into the pharmaceutical market increased 19% in CC, sales into the industrial market increased 17% in CC, and sales into the academic and government markets increased 4% in CC. Recurring…

  Waters (NYSE:WAT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:50 AM. Here's what investors need to know about the announcement. Earnings Waters beat estimated earnings by 20.69%, reporting an EPS of $2.8 versus an estimate of $2.32.

Waters (NYSE:WAT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Waters will report an earnings per share (EPS) of $2.32.

Continued Ukraine-Russia war, soaring inflation, and the anticipated aggressive interest rate hikes later this year have made the stock market extremely volatile lately. Amid these circumstances, it could be wise to invest in high-quality stocks KLA Corporation (KLAC), Mettler-Toledo (MTD), Dolby (DLB), and Waters (WAT), which are down more than…

Waters Corp (NYSE: WAT) repo